About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland
March 25, 2015
Click here to read more
Post navigation
Previous Post
Appendix 4E Preliminary Final Financial Report
Next Post
Phosphagenics Appoints Three New Directors
Related Posts
Ethics Approval received for Phase III Clinical Trial
December 22, 2022
December 22, 2022
Phosphagenics Full Year Financial Results
February 28, 2017
Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete
December 12, 2016